National Bank of Canada’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9	Closed	-$372	–	2883
2024 Q2	$372	Hold	9	–	–	﹤0.01%	2425
2024 Q1	$379	Buy	+9	New	+$379	﹤0.01%	2418